Neoadjuvant FOLFOX 4 versus FOLFOX 4 plus cetuximab versus immediate surgery for high-risk stage II and III colon cancers: A phase II multicentre randomised controlled trial (PRODIGE 22)
Open Access
- 18 September 2017
- journal article
- research article
- Published by Elsevier in Annals of Oncology
- Vol. 28 (suppl_5) , v159